Athenex, Inc.
ACETAMIDO-PHENYLTETRAZOLE DERIVATIVES AND METHODS OF USING THE SAME

Last updated:

Abstract:

The present disclosure relates to compounds of Formula (IA) ##STR00001## and to their prodrugs, pharmaceutically acceptable salts, pharmaceutical compositions, methods of use, and methods for their preparation. The compounds disclosed herein are useful for the treatment of disorders in which P-glycoprotein and/or cytochrome P450 (e.g. CYP3A4) is modulated (e.g., cancers which have developed multi-drug resistance).

Status:
Application
Type:

Utility

Filling date:

7 Oct 2021

Issue date:

7 Apr 2022